Table of Contents 1 Market Overview 1.1 Parkinsons disease Drug Introduction 1.2 Market Analysis by Type 1.2.1 Carbidopa/Levodopa 1.2.2 Dopamine Receptor Agonists 1.2.3 MAO-Inhibitors 1.3 Market Analysis by Applications 1.3.1 Hospital 1.3.2 Online 1.3.3 Retail Pharmacies 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 Italy Market States and Outlook (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2013-2023) 1.4.3.2 Japan Market States and Outlook (2013-2023) 1.4.3.3 Korea Market States and Outlook (2013-2023) 1.4.3.4 India Market States and Outlook (2013-2023) 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2013-2023) 1.4.4.2 Egypt Market States and Outlook (2013-2023) 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023) 1.4.4.4 South Africa Market States and Outlook (2013-2023) 1.4.4.5 Nigeria Market States and Outlook (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Teva 2.1.1 Business Overview 2.1.2 Parkinsons disease Drug Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Teva Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Novartis AG 2.2.1 Business Overview 2.2.2 Parkinsons disease Drug Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Novartis AG Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 GSK 2.3.1 Business Overview 2.3.2 Parkinsons disease Drug Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 GSK Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 AbbVie 2.4.1 Business Overview 2.4.2 Parkinsons disease Drug Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 AbbVie Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Merck 2.5.1 Business Overview 2.5.2 Parkinsons disease Drug Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Merck Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Boehringer Ingelheim 2.6.1 Business Overview 2.6.2 Parkinsons disease Drug Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Boehringer Ingelheim Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 Impax Laboratories 2.7.1 Business Overview 2.7.2 Parkinsons disease Drug Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Impax Laboratories Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Lundbeck 2.8.1 Business Overview 2.8.2 Parkinsons disease Drug Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Lundbeck Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 Sun Pharma 2.9.1 Business Overview 2.9.2 Parkinsons disease Drug Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Sun Pharma Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 Wockhardt 2.10.1 Business Overview 2.10.2 Parkinsons disease Drug Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Wockhardt Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.11 UCB 2.11.1 Business Overview 2.11.2 Parkinsons disease Drug Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 UCB Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.12 Valeant Pharmaceuticals 2.12.1 Business Overview 2.12.2 Parkinsons disease Drug Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 Valeant Pharmaceuticals Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.13 Acadia 2.13.1 Business Overview 2.13.2 Parkinsons disease Drug Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 Acadia Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Parkinsons disease Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017) 3.1 Global Parkinsons disease Drug Sales and Market Share by Manufacturer (2016-2017) 3.2 Global Parkinsons disease Drug Revenue and Market Share by Manufacturer (2016-2017) 3.3 Market Concentration Rate 3.3.1 Top 3 Parkinsons disease Drug Manufacturer Market Share in 2017 3.3.2 Top 6 Parkinsons disease Drug Manufacturer Market Share in 2017 3.4 Market Competition Trend 4 Global Parkinsons disease Drug Market Analysis by Regions 4.1 Global Parkinsons disease Drug Sales, Revenue and Market Share by Regions 4.1.1 Global Parkinsons disease Drug Sales and Market Share by Regions (2013-2018) 4.1.2 Global Parkinsons disease Drug Revenue and Market Share by Regions (2013-2018) 4.2 North America Parkinsons disease Drug Sales and Growth Rate (2013-2018) 4.3 Europe Parkinsons disease Drug Sales and Growth Rate (2013-2018) 4.4 Asia-Pacific Parkinsons disease Drug Sales and Growth Rate (2013-2018) 4.5 South America Parkinsons disease Drug Sales and Growth Rate (2013-2018) 4.6 Middle East and Africa Parkinsons disease Drug Sales and Growth Rate (2013-2018) 5 North America Parkinsons disease Drug by Countries 5.1 North America Parkinsons disease Drug Sales, Revenue and Market Share by Countries 5.1.1 North America Parkinsons disease Drug Sales and Market Share by Countries (2013-2018) 5.1.2 North America Parkinsons disease Drug Revenue and Market Share by Countries (2013-2018) 5.2 United States Parkinsons disease Drug Sales and Growth Rate (2013-2018) 5.3 Canada Parkinsons disease Drug Sales and Growth Rate (2013-2018) 5.4 Mexico Parkinsons disease Drug Sales and Growth Rate (2013-2018) 6 Europe Parkinsons disease Drug by Countries 6.1 Europe Parkinsons disease Drug Sales, Revenue and Market Share by Countries 6.1.1 Europe Parkinsons disease Drug Sales and Market Share by Countries (2013-2018) 6.1.2 Europe Parkinsons disease Drug Revenue and Market Share by Countries (2013-2018) 6.2 Germany Parkinsons disease Drug Sales and Growth Rate (2013-2018) 6.3 UK Parkinsons disease Drug Sales and Growth Rate (2013-2018) 6.4 France Parkinsons disease Drug Sales and Growth Rate (2013-2018) 6.5 Russia Parkinsons disease Drug Sales and Growth Rate (2013-2018) 6.6 Italy Parkinsons disease Drug Sales and Growth Rate (2013-2018) 7 Asia-Pacific Parkinsons disease Drug by Countries 7.1 Asia-Pacific Parkinsons disease Drug Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Parkinsons disease Drug Sales and Market Share by Countries (2013-2018) 7.1.2 Asia-Pacific Parkinsons disease Drug Revenue and Market Share by Countries (2013-2018) 7.2 China Parkinsons disease Drug Sales and Growth Rate (2013-2018) 7.3 Japan Parkinsons disease Drug Sales and Growth Rate (2013-2018) 7.4 Korea Parkinsons disease Drug Sales and Growth Rate (2013-2018) 7.5 India Parkinsons disease Drug Sales and Growth Rate (2013-2018) 7.6 Southeast Asia Parkinsons disease Drug Sales and Growth Rate (2013-2018) 8 South America Parkinsons disease Drug by Countries 8.1 South America Parkinsons disease Drug Sales, Revenue and Market Share by Countries 8.1.1 South America Parkinsons disease Drug Sales and Market Share by Countries (2013-2018) 8.1.2 South America Parkinsons disease Drug Revenue and Market Share by Countries (2013-2018) 8.2 Brazil Parkinsons disease Drug Sales and Growth Rate (2013-2018) 8.3 Argentina Parkinsons disease Drug Sales and Growth Rate (2013-2018) 8.4 Colombia Parkinsons disease Drug Sales and Growth Rate (2013-2018) 9 Middle East and Africa Parkinsons disease Drug by Countries 9.1 Middle East and Africa Parkinsons disease Drug Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Parkinsons disease Drug Sales and Market Share by Countries (2013-2018) 9.1.2 Middle East and Africa Parkinsons disease Drug Revenue and Market Share by Countries (2013-2018) 9.2 Saudi Arabia Parkinsons disease Drug Sales and Growth Rate (2013-2018) 9.3 UAE Parkinsons disease Drug Sales and Growth Rate (2013-2018) 9.4 Egypt Parkinsons disease Drug Sales and Growth Rate (2013-2018) 9.5 Nigeria Parkinsons disease Drug Sales and Growth Rate (2013-2018) 9.6 South Africa Parkinsons disease Drug Sales and Growth Rate (2013-2018) 10 Global Parkinsons disease Drug Market Segment by Type 10.1 Global Parkinsons disease Drug Sales, Revenue and Market Share by Type (2013-2018) 10.1.1 Global Parkinsons disease Drug Sales and Market Share by Type (2013-2018) 10.1.2 Global Parkinsons disease Drug Revenue and Market Share by Type (2013-2018) 10.2 Carbidopa/Levodopa Sales Growth and Price 10.2.1 Global Carbidopa/Levodopa Sales Growth (2013-2018) 10.2.2 Global Carbidopa/Levodopa Price (2013-2018) 10.3 Dopamine Receptor Agonists Sales Growth and Price 10.3.1 Global Dopamine Receptor Agonists Sales Growth (2013-2018) 10.3.2 Global Dopamine Receptor Agonists Price (2013-2018) 10.4 MAO-Inhibitors Sales Growth and Price 10.4.1 Global MAO-Inhibitors Sales Growth (2013-2018) 10.4.2 Global MAO-Inhibitors Price (2013-2018) 11 Global Parkinsons disease Drug Market Segment by Application 11.1 Global Parkinsons disease Drug Sales Market Share by Application (2013-2018) 11.2 Hospital Sales Growth (2013-2018) 11.3 Online Sales Growth (2013-2018) 11.4 Retail Pharmacies Sales Growth (2013-2018) 12 Parkinsons disease Drug Market Forecast (2018-2023) 12.1 Global Parkinsons disease Drug Sales, Revenue and Growth Rate (2018-2023) 12.2 Parkinsons disease Drug Market Forecast by Regions (2018-2023) 12.2.1 North America Parkinsons disease Drug Market Forecast (2018-2023) 12.2.2 Europe Parkinsons disease Drug Market Forecast (2018-2023) 12.2.3 Asia-Pacific Parkinsons disease Drug Market Forecast (2018-2023) 12.2.4 South America Parkinsons disease Drug Market Forecast (2018-2023) 12.2.5 Middle East and Africa Parkinsons disease Drug Market Forecast (2018-2023) 12.3 Parkinsons disease Drug Market Forecast by Type (2018-2023) 12.3.1 Global Parkinsons disease Drug Sales Forecast by Type (2018-2023) 12.3.2 Global Parkinsons disease Drug Market Share Forecast by Type (2018-2023) 12.4 Parkinsons disease Drug Market Forecast by Application (2018-2023) 12.4.1 Global Parkinsons disease Drug Sales Forecast by Application (2018-2023) 12.4.2 Global Parkinsons disease Drug Market Share Forecast by Application (2018-2023) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

List of Tables and Figures Figure Parkinsons disease Drug Picture Table Product Specifications of Parkinsons disease Drug Figure Global Sales Market Share of Parkinsons disease Drug by Types in 2017 Table Parkinsons disease Drug Types for Major Manufacturers Figure Carbidopa/Levodopa Picture Figure Dopamine Receptor Agonists Picture Figure MAO-Inhibitors Picture Figure Parkinsons disease Drug Sales Market Share by Applications in 2017 Figure Hospital Picture Figure Online Picture Figure Retail Pharmacies Picture Figure United States Parkinsons disease Drug Revenue (Value) and Growth Rate (2013-2023) Figure Canada Parkinsons disease Drug Revenue (Value) and Growth Rate (2013-2023) Figure Mexico Parkinsons disease Drug Revenue (Value) and Growth Rate (2013-2023) Figure Germany Parkinsons disease Drug Revenue (Value) and Growth Rate (2013-2023) Figure France Parkinsons disease Drug Revenue (Value) and Growth Rate (2013-2023) Figure UK Parkinsons disease Drug Revenue (Value) and Growth Rate (2013-2023) Figure Russia Parkinsons disease Drug Revenue (Value) and Growth Rate (2013-2023) Figure Italy Parkinsons disease Drug Revenue (Value) and Growth Rate (2013-2023) Figure China Parkinsons disease Drug Revenue (Value) and Growth Rate (2013-2023) Figure Japan Parkinsons disease Drug Revenue (Value) and Growth Rate (2013-2023) Figure Korea Parkinsons disease Drug Revenue (Value) and Growth Rate (2013-2023) Figure India Parkinsons disease Drug Revenue (Value) and Growth Rate (2013-2023) Figure Southeast Asia Parkinsons disease Drug Revenue (Value) and Growth Rate (2013-2023) Figure Brazil Parkinsons disease Drug Revenue (Value) and Growth Rate (2013-2023) Figure Egypt Parkinsons disease Drug Revenue (Value) and Growth Rate (2013-2023) Figure Saudi Arabia Parkinsons disease Drug Revenue (Value) and Growth Rate (2013-2023) Figure South Africa Parkinsons disease Drug Revenue (Value) and Growth Rate (2013-2023) Figure Nigeria Parkinsons disease Drug Revenue (Value) and Growth Rate (2013-2023) Table Teva Basic Information, Manufacturing Base and Competitors Table Teva Parkinsons disease Drug Type and Applications Table Teva Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Novartis AG Basic Information, Manufacturing Base and Competitors Table Novartis AG Parkinsons disease Drug Type and Applications Table Novartis AG Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table GSK Basic Information, Manufacturing Base and Competitors Table GSK Parkinsons disease Drug Type and Applications Table GSK Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table AbbVie Basic Information, Manufacturing Base and Competitors Table AbbVie Parkinsons disease Drug Type and Applications Table AbbVie Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Merck Basic Information, Manufacturing Base and Competitors Table Merck Parkinsons disease Drug Type and Applications Table Merck Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors Table Boehringer Ingelheim Parkinsons disease Drug Type and Applications Table Boehringer Ingelheim Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Impax Laboratories Basic Information, Manufacturing Base and Competitors Table Impax Laboratories Parkinsons disease Drug Type and Applications Table Impax Laboratories Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Lundbeck Basic Information, Manufacturing Base and Competitors Table Lundbeck Parkinsons disease Drug Type and Applications Table Lundbeck Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Sun Pharma Basic Information, Manufacturing Base and Competitors Table Sun Pharma Parkinsons disease Drug Type and Applications Table Sun Pharma Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Wockhardt Basic Information, Manufacturing Base and Competitors Table Wockhardt Parkinsons disease Drug Type and Applications Table Wockhardt Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table UCB Basic Information, Manufacturing Base and Competitors Table UCB Parkinsons disease Drug Type and Applications Table UCB Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Valeant Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Valeant Pharmaceuticals Parkinsons disease Drug Type and Applications Table Valeant Pharmaceuticals Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Acadia Basic Information, Manufacturing Base and Competitors Table Acadia Parkinsons disease Drug Type and Applications Table Acadia Parkinsons disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Global Parkinsons disease Drug Sales by Manufacturer (2016-2017) Figure Global Parkinsons disease Drug Sales Market Share by Manufacturer in 2016 Figure Global Parkinsons disease Drug Sales Market Share by Manufacturer in 2017 Table Global Parkinsons disease Drug Revenue by Manufacturer (2016-2017) Figure Global Parkinsons disease Drug Revenue Market Share by Manufacturer in 2016 Figure Global Parkinsons disease Drug Revenue Market Share by Manufacturer in 2017 Figure Top 3 Parkinsons disease Drug Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Parkinsons disease Drug Manufacturer (Revenue) Market Share in 2017 Figure Global Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure Global Parkinsons disease Drug Revenue and Growth Rate (2013-2018) Table Global Parkinsons disease Drug Sales by Regions (2013-2018) Table Global Parkinsons disease Drug Sales Market Share by Regions (2013-2018) Table Global Parkinsons disease Drug Revenue by Regions (2013-2018) Figure Global Parkinsons disease Drug Revenue Market Share by Regions in 2013 Figure Global Parkinsons disease Drug Revenue Market Share by Regions in 2017 Figure North America Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure Europe Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure Asia-Pacific Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure South America Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure Middle East and Africa Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure North America Parkinsons disease Drug Revenue and Growth Rate (2013-2018) Table North America Parkinsons disease Drug Sales by Countries (2013-2018) Table North America Parkinsons disease Drug Sales Market Share by Countries (2013-2018) Figure North America Parkinsons disease Drug Sales Market Share by Countries in 2013 Figure North America Parkinsons disease Drug Sales Market Share by Countries in 2017 Table North America Parkinsons disease Drug Revenue by Countries (2013-2018) Table North America Parkinsons disease Drug Revenue Market Share by Countries (2013-2018) Figure North America Parkinsons disease Drug Revenue Market Share by Countries in 2013 Figure North America Parkinsons disease Drug Revenue Market Share by Countries in 2017 Figure United States Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure Canada Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure Mexico Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure Europe Parkinsons disease Drug Revenue and Growth Rate (2013-2018) Table Europe Parkinsons disease Drug Sales by Countries (2013-2018) Table Europe Parkinsons disease Drug Sales Market Share by Countries (2013-2018) Table Europe Parkinsons disease Drug Revenue by Countries (2013-2018) Figure Europe Parkinsons disease Drug Revenue Market Share by Countries in 2016 Figure Europe Parkinsons disease Drug Revenue Market Share by Countries in 2017 Figure Germany Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure UK Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure France Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure Russia Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure Italy Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure Asia-Pacific Parkinsons disease Drug Revenue and Growth Rate (2013-2018) Table Asia-Pacific Parkinsons disease Drug Sales by Countries (2013-2018) Table Asia-Pacific Parkinsons disease Drug Sales Market Share by Countries (2013-2018) Figure Asia-Pacific Parkinsons disease Drug Sales Market Share by Countries 2017 Table Asia-Pacific Parkinsons disease Drug Revenue by Countries (2013-2018) Figure Asia-Pacific Parkinsons disease Drug Revenue Market Share by Countries 2017 Figure China Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure Japan Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure Korea Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure India Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure Southeast Asia Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure South America Parkinsons disease Drug Revenue and Growth Rate (2013-2018) Table South America Parkinsons disease Drug Sales by Countries (2013-2018) Table South America Parkinsons disease Drug Sales Market Share by Countries (2013-2018) Figure South America Parkinsons disease Drug Sales Market Share by Countries in 2017 Table South America Parkinsons disease Drug Revenue by Countries (2013-2018) Table South America Parkinsons disease Drug Revenue Market Share by Countries (2013-2018) Figure South America Parkinsons disease Drug Revenue Market Share by Countries in 2017 Figure Brazil Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure Argentina Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure Colombia Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure Middle East and Africa Parkinsons disease Drug Revenue and Growth Rate (2013-2018) Table Middle East and Africa Parkinsons disease Drug Sales by Countries (2013-2018) Table Middle East and Africa Parkinsons disease Drug Sales Market Share by Countries (2013-2018) Figure Middle East and Africa Parkinsons disease Drug Sales Market Share by Countries in 2017 Table Middle East and Africa Parkinsons disease Drug Revenue by Countries (2013-2018) Table Middle East and Africa Parkinsons disease Drug Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Parkinsons disease Drug Revenue Market Share by Countries in 2013 Figure Middle East and Africa Parkinsons disease Drug Revenue Market Share by Countries in 2017 Figure Saudi Arabia Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure UAE Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure Egypt Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure Nigeria Parkinsons disease Drug Sales and Growth Rate (2013-2018) Figure South Africa Parkinsons disease Drug Sales and Growth Rate (2013-2018) Table Global Parkinsons disease Drug Sales by Type (2013-2018) Table Global Parkinsons disease Drug Sales Share by Type (2013-2018) Table Global Parkinsons disease Drug Revenue by Type (2013-2018) Table Global Parkinsons disease Drug Revenue Share by Type (2013-2018) Figure Global Carbidopa/Levodopa Sales Growth (2013-2018) Figure Global Carbidopa/Levodopa Price (2013-2018) Figure Global Dopamine Receptor Agonists Sales Growth (2013-2018) Figure Global Dopamine Receptor Agonists Price (2013-2018) Figure Global MAO-Inhibitors Sales Growth (2013-2018) Figure Global MAO-Inhibitors Price (2013-2018) Table Global Parkinsons disease Drug Sales by Application (2013-2018) Table Global Parkinsons disease Drug Sales Share by Application (2013-2018) Figure Global Online Sales Growth (2013-2018) Figure Global Retail Pharmacies Sales Growth (2013-2018) Figure Global Parkinsons disease Drug Sales, Revenue and Growth Rate (2018-2023) Table Global Parkinsons disease Drug Sales Forecast by Regions (2018-2023) Table Global Parkinsons disease Drug Market Share Forecast by Regions (2018-2023) Figure North America Sales Parkinsons disease Drug Market Forecast (2018-2023) Figure Europe Sales Parkinsons disease Drug Market Forecast (2018-2023) Figure Asia-Pacific Sales Parkinsons disease Drug Market Forecast (2018-2023) Figure South America Sales Parkinsons disease Drug Market Forecast (2018-2023) Figure Middle East and Africa Sales Parkinsons disease Drug Market Forecast (2018-2023) Table Global Parkinsons disease Drug Sales Forecast by Type (2018-2023) Table Global Parkinsons disease Drug Market Share Forecast by Type (2018-2023) Table Global Parkinsons disease Drug Sales Forecast by Application (2018-2023) Table Global Parkinsons disease Drug Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

Teva Novartis AG GSK AbbVie Merck Boehringer Ingelheim Impax Laboratories Lundbeck Sun Pharma Wockhardt UCB Valeant Pharmaceuticals Acadia